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Summary: The 15 kDa selenoprotein (Sepl5) is one of several recently 
identified selenoproteins. It contains a single selenocysteine residue in the 
middle of a 162-amino acid open reading frame and has no detectable 
homology to known proteins. The human Sepl5 gene spans 5 1 kb, has 5 
exons and is located on chromosome 1 at position p3 1. The gene contains 
two single nucleotide polymorphisms in the 3'-untranslated region (3'-UTR) 
including one in the SECIS element, that are distributed differently between 
Caucasians and African Americans. Sep 1 5 localizes to the endoplasmic 
reticulum where it is tightly bound to UDP-glucose:glycoprotein 
glucosyltransferase, a protein involved in the quality control of protein 
folding. Sepl5 may be involved in the chemopreventive effect of dietary 
selenium. This hypothesis is based on its differential expression in normal 
and malignant tissues, the distribution and functional consequences of 
natural polymorphisms within its gene, and the location of the Sepl 5 gene in 
a region that is often altered in a variety of cancers. 
Introduction 
The number of selenoproteins identified thus far in vertebrates stands at 22 
(see Chapter 9). The function of only a few of these proteins is known. Since 
there is mounting evidence that at least some of the beneficial effects of 
selenium on health, including its anticarcinogenic properties, are mediated 
through selenoproteins, it is important to identify, characterize and determine 
functions for as many selenoproteins as possible. 
Selenium: Its molecular biology and role in human health 
One of these proteins for which the function is not known is the 15 kDa 
selenoprotein (Sepl5). Sepl5 was discovered about three years ago [ l ]  when 
it was purified from human T cells as a protein that was strongly radiolabeled 
when cells were grown in the presence of 7 5 ~ e .  The Sepl5 cDNA sequence 
was deduced from the analysis of the EST database following sequencing of 
several tryptic peptides obtained from the isolated selenoprotein. The new 
open reading frame (ORF) contained an in-frame TGA codon (Figure 1) that 
was predicted to encode selenocysteine (Sec). This conclusion was also 
based on the presence of selenium in the protein and the fact that sequences 
downstream of the in-frame TGA matched those predicted to encode tryptic 
peptides in the isolated human T-cell Sepl5. 
Analysis of human Sepl5 sequence using the EST database revealed that 
this selenoprotein was expressed in a variety of human cell types and 
identified its orthologs in other mammals. However, Sepl5 sequences had no 
homology to known proteins making this protein a difficult target for 
functional characterization. Recent biochemical and genetic studies [2-41 
significantly advanced our understanding of the genetics and biochemistry of 
Sep 15. These studies identified a binding partner for Sep 15 that implicated 
this selenoprotein in the quality control of protein folding [4] and revealed 
unexpected genetic factors that implicated Sepl5 in the dietary effect of 
selenium in cancer prevention [2,3]. These studies are discussed in this 
chapter. 
The human Sepl5 gene 
The complete sequence of the human Sepl5 gene has been recently 
determined [2]. The gene spans a region of 5 1 kilobase pairs on chromosome 
1 and consists of five exons and four introns (see Figure 1). The 5'- 
untranslated region (5'-UTR) and the first 27 amino acid residues of a 
putative signal peptide are included in the first exon. This peptide is not 
present in Sepl5 isolated from human T cells [ l ]  consistent with 
posttranslational processing of the signal peptide. Such gene organization, 
when the coding sequence for an amino terminal signal peptide is located in 
a separate exon, has been observed for many other mammalian proteins. The 
largest exon in the human Sepl5 gene is exon 5 which encodes C-terminal 
sequences and also includes the 3'-UTR. The TGA codon that dictates Sec 
incorporation into the resulting Sepl5 gene product is located in exon 3. The 
site of initiation of transcription in the Sepl5 gene was determined by primer 
extension and was found to lack a TATA box that is often found upstream of 
RNA polymerase 11 transcribed mammalian genes [2]. 
Two polymorphic sites, which are located in the 3'-UTR at positions 81 1 
and 1125 in human cDNA, have been identified [I-31 and their locations in 
the Sepl5 mRNA sequence are shown in Figure 1. In all DNA samples 
examined to date, c8" is found associated with G"*' and T'" is associated 
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with A~~~~ suggesting the presence of two alleles. Interestingly, the 
polymorphism at 1125 site is located in the apical loop of selenocysteine 
insertion sequence (SECIS) element. 
lntron 1 lntron lntron 3 lntron 
SECIS 
element 
81 1 CIT + 1 125GlA ATG TGA TAA 
~',f  , , f ,  , f 3' 
I I I 1  
Figure 1. Structural organization of the human 15 kDa selenoprotein gene. In the upper panel, 
the exon-intron organization and relative sizes of exons and introns in the 5 1 -kb human Sepl5 
gene are shown. Horizontal lines correspond to introns and flanking regions, and the closed 
squares to exons. In the lower panel, the organization of the human cDNA sequence obtained 
by splicing of the Sepl5 gene is shown. The relative positions of the ATG initiation and the 
TGA Sec codons, the TAA termination signal and the detected polymorphisms (81 1ClT and 
1125GlA) are shown. The location of 1125GlA polymorphism in the apical loop of the SECIS 
element is also indicated. The long horizontal line corresponds to the Sepl5 cDNA, and short 
vertical lines correspond to exon-exon junctions. Numbers under junction sites correspond to 
last nucleotides in preceding exons. 
Amino acid sequences 
Coding sequences within Sepl5 genes do not show detectable homology to 
known proteins, nor do they have clear sequence motifs indicative of a 
protein structure, cofactor composition or function (Figure 2). However, 
Sepl5 genes were found in a wide variety of animals, including rats, mice, 
zebrafish, fruit flies and nematodes (Figure 2) [1,2]. The position of Sec is 
conserved in the Sepl5 vertebrate sequences, whereas in insects and 
nematodes, Sec is replaced with Cys (Figure 2). Homology analyses also 
indicate that vertebrate Sep 15 sequences are highly conserved. For example, 
mature human and mouse Sepl5 differ by only three amino acid residues. 
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Rat MAAGQGGWLRPALGL RLLLATAFQAVSALG AEFSSEACRELGFSS 45 
Mouse MAAGQGGWLRPALGL RLLLATAFQAVSALG AEFASEACRELGFSS 45 
Human MAAGPSGCLVPAFGL RLLLATVLQAVSAFG AEFSSEACRELGFSS 45 
Bovine MAARRDGWLGPAFGL RLLLATVLQTVSALG AEFSSESCRELGFSS 45 
Ciona MVGPKRRKNGAIISK LLQLFLLGMIHSHAE ASLSAQECADLGFSS 45 
Shrimp ------- MMVDPGGI GLFIAATLLSIVEAV QELSTEECFAVGLNK 38  
Droso --------------- --------------- 0 
C.eleg --------- MWVIFL LLAAVVSPMFGEVEE YKIDVEECKAAGFNP 36 
Rat N-LL$SS$DL~GQFN $LPLDPV@RG~CQEE AQFETKKLYAG~B 89 
Mouse N-LL~SS~DL~GQFN &LPLDPV~RG~CQEE AQFETKKLYAG~@~~ 89 
Human N-LL@SS~D~~GQFN ~LQLDPD~RG$CQEE AQFETKKLYAG~& . x . , ~ ~ - ~ ~ :  v 8 9 
Bovine N-LL~SS~DL~GQFN ~LQLDPD@RG~~!CQEE A Q F E T K K L Y A G ~ ~  89
Ciona E-LM~GS&SL~PKFN BTMLEDD~KK~CQSE VEEDTAKRFHS%~~~ 8 9 
Shrimp ANLL~SS~DT~,$KEFN RDVLEAN&RG@CNVD DVNATPTKYPR@@$$ 8 3 
Droso ---MQSS~EK~DDFG @DTIKPQ~KQ$CTLD QQPAAQRTYA 42 
C . eleg ETLK~GL~ER~SDYH ~ETLLTD~~LQ~CIKE -EE FKHEKYPT#@$& 8 0 
Rat $~~G@KLGRF~~V@ RSDKPKL&R-GLQI I$YR@@SD~VLKgLDD 133 
Mouse ~$$G~KLGRF~~v~&" VRSDKPKLER-GLQI ~Y~~SD$~VLK$$LDD 13 3 
Human ~@G~KLGRF&v~$~~ VRSDKPKL~R-GLQI ~~Y&$SD~VL~LDD 13 3 
Bovine ~ # G ~ K L G R F ~ & V ~ ~  VRSDKPKL$K-GLQI ~Y@~SD&~LK&LDD 133 
Ciona ~@G~KIGRY~$V$@ VKGEKSRA~S-NLKI ~Y~AD@VIK@LNE 13 3 
Shrimp @ @ G ~ R L G A F V  VKSDRPAAgP-NLTI @Y-AD'$I IK&MDE 12 7 
Droso l. *- B&T~KFRAY&I&# a - - T a , < , A ~ ~ ?  lT IQSGRPAK~P-NLQI ~Y~&&LD~VVK~LDA 86 
c . eleg F$E~NLARF&@~V@$(~ VHKDMARQFGGKVKV $H&;&VR~QVR~KDA 12 5 
Rat N G N I A E E ~ S I L ~ ~  ~SVEE~LSEK~~(ERI- ---------------- 162 
Mouse NGNIAEE$SIL@&N~ QSVEE@LSEK~ERI- ---------------- 162 
Human N G N I A E E ~ S I L ~ ~  QSVEE~LSEK~ERI- --------------- 162 
Bovine SGNIAEE~SIL@$'N& ~SVEE~LSEK~ERI- -- ------------- 162 
Ciona D E Q V Q D T ~ S I T ~ ~  QSVEE~LNEK'#IRV- ----------------I62 
Shrimp DGDVMET~IIID~N$ $SXEE@LNTY$ILPG QRGRSR----------I63 
Droso SGKVQET#SIT~$! ~TVEE~FETH@AKDG AGKNSYSVVEDADGD 132 
C. eleg DFKTKEV~SVE@D~ DTLIDEFNQW~E--- --------------- 153 
Rat ----------- 162 
Mouse ----------- 162 
Human ----------- 162 
Bovine ----------- 162 
Ciona ----------- 162 
Shrimp ----------- 163 
Droso DDEDYLRTNRI 143 
C.eleg ----------- 153 
Figure 2. Amino acid alignment of animal Sepl5 sequences. Residues identical in all 
sequences are highlighted. U represents selenocysteine and is shown by a closed circle above 
the sequence. Accession numbers for human and mouse Sepl5 sequences are AF05 1894 and 
AF288740, respectively. Rat, bovine, Ciona intestinals (Ciona) and Penaeus vannamei 
(shrimp) sequences were assembled from EST sequences. The Drosophila (Droso) Sepl5 
sequence (accession number AE003523) was predicted by the Drosophila genome project. 
This sequence appears to lack the first exon containing the N-terminal signal peptide. The C. 
elegans (C.eleg) sequence (accession number AC024872) was predicted by the C. elegans 
Genome Project and corrected to remove an additional intron. 
The 15 kDa selenoprotein (Sepl5) 
Pattern of expression 
Following the initial EST analyses [I], expression of the Sepl5 gene was 
examined in a number of human and mouse tissues by northern analysis and 
immunoblot assays [2]. Highest levels of gene expression were observed in 
prostate, liver, kidney, testes and brain, while lower levels were found in 
lung, spleen and skeletal muscle. 
The high expression of Sep15 in the prostate may be relevant to the recent 
observation of an abundant 75~e-labeled selenoprotein that migrated as -1 5- 
16 kDa species on SDS PAGE gels [5]. In selenium deficiency, expression of 
this protein was conserved, in contrast to that of another selenoprotein, 
glutathione peroxidase 1. However, -1 5- 16 kDa protein has not been isolated 
or its gene sequenced, making it difficult to compare this protein and Sepl5. 
Mammalian cells contain a number of selenoproteins with predicted 
molecular masses similar to that of mature Sepl5 [6]. Thus, the rat prostate 
15 kDa selenoprotein detected by Behne and colleagues [5] is either Sepl5, 
one of the selenoproteins identified recently by searching mammalian 
genomes with various bioinformatics tools (Chapter 9), or a protein yet to be 
characterized. 
Association of Sepl5 and UGTR 
Initial purification of Sepl5 from human T cells employed reversed-phase 
chromatography as a final isolation step. Thus, SeplS was isolated in a 
denatured state [I]. However, this protein migrated as -160 kDa species on 
native gels. This observation suggested that SeplS is either composed of 
multiple identical subunits or strongly binds another protein to form the 160 
kDa complex. Taking advantage of the high expression level of Sepl5 in the 
prostate, the protein was isolated in the native state from this organ by 
combination of conventional chromatography and HPLC [4]. 
Native Sepl5 was found to occur in a complex with a 150 kDa protein. 
The latter protein was then identified by methods of protein microchemistry 
as UDP-g1ucose:glycoprotein glucosyltransferase (UGTR), an endoplasmic 
reticulum-resident protein [7]. The function of UGTR is to glucosylate 
misfolded proteins, thus retaining them in the endoplasmic reticulum until 
they are correctly folded or transferring them to degradation pathways [8]. 
The Sepl5 gene was fused to a green florescent protein in order that the 
expressed fusion protein could be tracked intracellularly. Consistent with its 
association with UGTR, Sepl5 was localized to the endoplasmic reticulum 
[4]. Furthermore, the N-terminal signal peptide, which was cleaved in the 
mature protein, was found to be essential for its translocation. The C- 
terminal sequence of Sepl5 was not involved in retaining this protein in the 
endoplasmic reticulum, and most likely, Sepl5 is retained in this 
compartment by its association with UGTR. Sepl5 is the first known 
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endoplasmic reticulum-resident selenoprotein and its complex with UGTR 
suggests a role of selenium in the quality control of protein folding. 
Influence of the A ~ ~ ~ ~ / G ~ ~ ~ ~  polymorphism on selenoprotein expression 
The fact that the A ' ~ ~ ~ / G ~ ~ ~ ~  polymorphic site occurs in the apical loop of the 
SECIS element suggested that it might differentially influence the level of 
SeplS translation. This possibility prompted us to study the ability of 
polymorphisms in the SeplS gene to support selenoprotein expression, as 
well as to study the allelic frequencies within the human population and their 
association with malignancy. 
Initially, the ability of the nucleotide positions comprising the A ~ ~ ~ ~ / G ~ ~ ~ ~  
polymorphism to influence selenoprotein expression was examined [2,3]. 
The SeplS 3'-UTR, encoding one or the other polymorphism, was attached 
to the deiodinase 1 (Dl) gene in an expression vector. The levels of Dl  in the 
chimeric constructs were compared to that of wild type Dl  [2]. The level 
obtained with the construct was approximately 75% of that observed 
with wild type and the level with the GH2' construct was approximately 50% 
of that of wild type. These data suggested that the identity of the base at 
position 1 125 ultimately may influence Sep 1 5 levels. 
In contrast to the 1125 site, the base at position 81 1 did not influence the 
level of Sepl5 expression. That is, a T~"/G"~'  construct yielded 
approximately the same level of expression as c~"/G"~' and a c ~ ~ ~ / A ~ ~ ~ ~  
construct yielded approximately the same level of expression as T~"/A"~'  
[2,31. 
To further examine the consequences of the polymorphic nucleotide 
positions with regard to their ability to influence the translation of mRNAs 
containing an in-frame UGA codon, a construct was employed that permitted 
us to test SECIS function by monitoring expression levels of full size and 
truncated proteins. Again, the G form resulted in lower expression of the 
reported construct. Thus, the data examining SECIS element efficiency as a 
function of the two polymorphic positions in Sep15 clearly demonstrated that 
the identity of the base at position 1125 influences the level of UGA 
readthrough. However, in addition to influencing selenoprotein expression at 
concentrations of selenium provided by 10% fetal bovine serum in cell 
culture media, these polymorphisms differentially responded to additional 
selenium supplementation of culture media [2,3]. Although the allelic 
form resulted in lower SECIS efficiency compared to the form in the 
absence of selenium supplementation, it was more responsive to increasing 
selenium levels than the AHZ5 form. The possibility that these properties may 
have a role in cancer prevention is discussed below. 
The 15 kDa selenoprotein (Sepl5) 
Possible role of Sepl5 in cancer etiology 
The finding that the SeplS gene occurs in humans as two allelic forms 
allowed us to determine the frequencies at which these alleles are present in 
the human population. Over 700 samples were analyzed by the PCR 
amplification of the polymorphic region followed by diagnostic restriction 
enzyme digestion [3]. This analysis revealed surprising differences in allele 
frequencies between Caucasians and African Americans. In addition, this 
study revealed differences in allele frequencies obtained from tumors of 
breast or head and neck origin when compared to cancer-free individuals 
among African Americans [3]. Furthermore, loss of heterozygosity (LOH) at 
the Sep 15 gene locus was detected when DNA from circulating lymphocytes 
of an African American patient with a supraglotis tumor was compared to the 
DNA obtained from that tumor [3]. Development of cancer is often 
accompanied by the LOH at the sites that encode protective genes that are 
also called tumor suppressor genes. Thus, genetic changes at the Sepl5 locus 
suggest that the loss of the Sepl5 gene (or possibly a gene in the vicinity of 
the Sep15 gene) contributes to the development of certain cancers. 
The human Sep 15 gene is located on chromosome 1 at position p3 1. This 
region is commonly mutated or deleted in human cancers and the presence of 
a tumor suppressor gene on lp3 1 has been suggested, but its identity has not 
been established [9,10]. It is possible that the loss of one copy of Sep15 gene 
may result in a decrease in the biosynthesis of this selenoprotein gene 
product in malignant tissues relative to the corresponding normal tissues. 
The observation that natural polymorphisms found in the 3'-UTR of the 
Sep 15 gene may influence its translational efficiency in response to selenium 
levels may also be relevant to the putative role of the protein in cancer. It is 
possible that individuals representing different combinations of these two 
haplotypes may express different amounts of Sepl5 and, in addition, they 
may differentially respond to changes in dietary selenium (i.e., differentially 
control translational levels of Sepl5 in response to changes in selenium 
levels). 
The fact that prostate in both humans and mice expresses high levels of 
Sepl5 may also be relevant to the link between Sepl5 and cancer. Human 
selenium supplementation trials revealed that dietary selenium can reduce the 
incidence of prostate cancer [ l  11 and it is likely that the greatest protection is 
provided to those individuals with lower selenium intake. In addition, 
epidemiological data have indicated a statistically significant inverse 
correlation between selenium in the diet and prostate cancer [12]. However, 
the mechanism of cancer prevention by selenium is poorly characterized [13] 
and no selenoprotein has been implicated in such protection. The recent data 
on Sepl5 raise the possibility that this protein may function in the prevention 
of cancer and possibly serve as an agent by which selenium supplementation 
exerts its chemopreventive effect. 
Selenium: Its molecular biology and role in human health 
Although maximal protection against carcinogen-induced cancers in 
rodents has been achieved by providing dietary selenium in amounts 
exceeding levels that are necessary for maximal expression of GPxl and 
GPx3 [13; and see Chapters 8, 14 and 231, these studies should not 
necessarily be viewed as proof that selenoproteins are not involved in cancer 
prevention. It is possible that distinct selenoproteins exhibit different 
expression patterns at high concentrations of selenium or when individuals 
are under environmental or genetic stress, such as those that are predisposed 
to the risk of developing certain cancers. Consistent with this notion was the 
observation that liver tumors of TGFalc-myc double transgenic mice (a 
transgenic model of hepatocarcinoma) that were maintained on a selenium- 
sufficient diet had reduced levels of Sepl5 compared to adjacent hepatic 
tissues [2]. In addition, Sepl5 was essentially undetectable in a mouse 
prostate cancer cell line, while this protein was abundant in normal mouse 
prostate [2]. If lower levels of the Sepl5 predispose an individual to 
malignancy, then the observation of differences in SECIS element function 
between the two naturally occurring alleles in the human population may 
indicate a segment of the population who are either at greater risk of cancer 
or whom might benefit from selenium supplementation. These observations, 
together with the fact that alterations in the region on chromosome 1 where 
the Sepl5 gene is located is often associated with cancer progression suggest 
a possible role of Sep 15 in cancer etiology. 
Concluding remarks 
Sepl5 was discovered by virtue of the presence of selenium in the protein 
and the relative abundance of Sepl5 compared to other selenoproteins. 
However, characterization of its gene sequences failed to detect significant 
homology to known proteins. Recent studies on the selenoprotein have 
suggested insights into its function and a role in human health. Its 
identification as a binding partner to the UGTR protein implicates Sepl5 in 
the control of protein folding in the endoplasmic reticulum. In addition, 
several biochemical and genetic observations have suggested that Sepl5 may 
be involved in cancer development and may mediate, at least in part, the 
chemoprotective effect of selenium. While these data hold great promise, 
further studies are necessary to determine the relevance of Sepl5 to both 
protein folding and cancer prevention. 
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